Selected article for: "albumin total protein and blood cell"

Author: He, Chaobin; Wang, Jun; Sun, Shuxin; Zhang, Yu; Li, Shengping
Title: Immunomodulatory Effect after Irreversible Electroporation in Patients with Locally Advanced Pancreatic Cancer
  • Document date: 2019_5_12
  • ID: 1pbzbydu_6
    Snippet: . . Clinical Data Collection. The following clinical and radiological data were retrieved from medical record archived at Sun Yat-sen University Cancer Center, including age, gender, tumor size, tumor grade, tumor site, white blood cell (WBC) count, platelet (PLT) count, serum levels of alanine transaminase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), glutamyl transpeptidase (GGT), albumin (ALB), total bilirubin (TBIL), in.....
    Document: . . Clinical Data Collection. The following clinical and radiological data were retrieved from medical record archived at Sun Yat-sen University Cancer Center, including age, gender, tumor size, tumor grade, tumor site, white blood cell (WBC) count, platelet (PLT) count, serum levels of alanine transaminase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), glutamyl transpeptidase (GGT), albumin (ALB), total bilirubin (TBIL), indirect bilirubin (IBIL), Creactive protein (CRP), carcinoembryonic antigen (CEA), and carbohydrate antigen 19-9 (CA19-9). The inflammationbased indexes, including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), prognostic index (PI), and modified Glasgow Prognostic Score (mGPS), were also entered into this study. The thresholds for the clinical or radiological variables were used as the cutoff values. With the cutoff value of 1.47 and 165.29, NLR and PLR were associated with the optimal Youden indexes for OS and progression-free survival (PFS) prediction, respectively. The defined score of other inflammation-based indexes, such as PI and mGPS, had been described in previous studies [19] .

    Search related documents:
    Co phrase search for related documents
    • previous study and total bilirubin: 1, 2, 3, 4
    • previous study and tumor grade: 1
    • previous study and WBC count: 1
    • previous study and white blood cell: 1, 2, 3, 4, 5
    • previous study and Youden index: 1
    • prognostic index and serum level: 1, 2, 3
    • prognostic index and tumor size: 1, 2
    • prognostic index and WBC count: 1
    • prognostic index and white blood cell: 1, 2
    • prognostic index and Youden index: 1, 2
    • progression free os and serum level: 1, 2
    • progression free os and tumor grade: 1, 2
    • progression free os and tumor size: 1, 2, 3, 4
    • progression free os and white blood cell: 1
    • progression free os survival and serum level: 1, 2
    • progression free os survival and tumor grade: 1, 2
    • progression free os survival and tumor size: 1, 2, 3, 4
    • progression free os survival and white blood cell: 1
    • serum level and study enter: 1